Status:
UNKNOWN
Neurofeedback Intervention in Children With Autism Spectrum Disorder (ASD)
Lead Sponsor:
Shaheed Zulfiqar Ali Bhutto Medical University
Collaborating Sponsors:
Khyber Medical University Peshawar
Conditions:
Neurofeedback
Autistic Disorder
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
This project aims to: * explore the effectiveness of Neurofeedback therapy for children diagnosed with Autism Spectrum Disorder (ASD) * assess if cognitive functions are affected before and after Neu...
Detailed Description
Neurofeedback is a computer assisted programmed technique that functions by tracing brain electrical activity (EEG) and providing feedback about the brain activity and sends visual and acoustic signal...
Eligibility Criteria
Inclusion
- 7 to 17 year olds (diagnosed by their physician with autism, in accordance with DSM-V (Diagnostic Statistical Manual-V) diagnostic criteria
Exclusion
- Any child with a history of
- Brain injury
- Bipolar Disorder
- Tourette's Syndrome
- Uncontrolled seizure disorder
- Major psychiatric disorder
- Children on medications
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05254769
Start Date
November 15 2021
End Date
May 1 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal Medical and Dental College, Shaheed Zulfiqar Ali Bhutto Medical University
Islamabad, Pakistan, 44000